Literature DB >> 11680596

Unusual development of hepatocellular carcinoma in a patient with Crohn's disease.

M L Borum1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11680596     DOI： 10.1023/a:1011915032118

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

Review 1.  Hepatobiliary manifestations of inflammatory bowel disease.

Authors:  V Raj; D R Lichtenstein
Journal:  Gastroenterol Clin North Am       Date:  1999-06       Impact factor: 3.806

Review 2.  Hepatobiliary complications of inflammatory bowel disease: overview of the issues.

Authors:  W F Balistreri
Journal:  Inflamm Bowel Dis       Date:  1998-08       Impact factor: 5.325

Review 3.  Hepatocellular carcinoma.

Authors:  S Badvie
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

4.  Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto.

Authors:  G Riegler; R D'Incà; G C Sturniolo; G Corrao; C Del Vecchio Blanco; V Di Leo; R Carratù; M Ingrosso; M A Pelli; S Morini; D Valpiani; D Cantarini; P Usai; C Papi; R Caprilli
Journal:  Scand J Gastroenterol       Date:  1998-01       Impact factor: 2.423

5.  Hepatoma associated with ulcerative colitis: Report of a case.

Authors:  P M Smith
Journal:  Dis Colon Rectum       Date:  1974 Jul-Aug       Impact factor: 4.585

Review 6.  Hepatocellular carcinoma.

Authors:  K Okuda
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

Review 7.  Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.

Authors:  J Romagnuolo; D C Sadowski; E Lalor; L Jewell; A B Thomson
Journal:  Can J Gastroenterol       Date:  1998-10       Impact factor: 3.522
  7 in total
  5 in total

1.  Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine.

Authors:  Jason Samarasena; Mark Borgaonkar
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

2.  Hepatocellular carcinoma occurring in a Crohn's disease patient.

Authors:  Mitsuaki Ishida; Shigeyuki Naka; Hisanori Shiomi; Tomoyuki Tsujikawa; Akira Andoh; Tamio Nakahara; Yasuharu Saito; Yoshimasa Kurumi; Mikiko Takikita-Suzuki; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

3.  Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.

Authors:  Shawn C Chen; Oscar W Cummings; Michael P Hartley; Carol A Filomena; Won Kyoo Cho
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

4.  Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review.

Authors:  Kyle J Fortinsky; Ali Alali; Khursheed Jeejeebhoy; Sandra Fischer; Morris Sherman; Scott Fung
Journal:  Case Rep Gastrointest Med       Date:  2014-12-22

5.  Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?

Authors:  Youssef Botros; Mary Mathews; Hiren Patel; Nihar Shah; Walid Baddoura; Andrew de la Torre
Journal:  Case Rep Gastrointest Med       Date:  2015-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.